Alaunos Therapeutics Inc (TCRT): Down 37 cents or 5% on no news today so...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	154
Boards Moderated	0
Alias Born	08/17/2006

Plegee

Re: None

Friday, 05/19/2017 5:23:35 PM

Friday, May 19, 2017 5:23:35 PM

Down 37 cents or 5% on no news today so the MM can play his little games and have all those 7 call options expire worthless. Blatant manipulation. Closed at $6.99 . . . . what a coincidence with those 2700+ 7 strike options open.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TCRT News

Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:46:36 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:44:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:05:27 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:43:20 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:58:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:45:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:47:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:30:50 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:25:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:00:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 01:00:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 12:30:01 PM
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives • GlobeNewswire Inc. • 11/14/2023 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:34:33 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/01/2023 04:20:04 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:37:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:16:29 PM
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 08/14/2023 08:05:34 PM
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies • GlobeNewswire Inc. • 06/29/2023 11:00:53 AM
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting • GlobeNewswire Inc. • 05/25/2023 09:00:52 PM

More TCRT News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover